Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elihu Estey

Showing results (41-50 of 158) with videos related to

Pageof 16
Sort By:
Blood|June 10, 2021
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimalElihu Estey, Robert P Hasserjian, Hartmut Döhner
Leukemia Research|May 4, 2004
FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotypeMiloslav Beran, Rajyalakshmi Luthra, Hagop Kantarjian, et al.
Mayo Clinic Proceedings|February 14, 2006
Adult acute myeloid leukemiaElias J Jabbour, Elihu Estey, Hagop M Kantarjian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Decitabine in older adults with acute myeloid leukemia: why was the dream broken?Hagop Kantarjian, Wyndham Wilson, Farhad Ravandi, et al.
Pediatric Blood & Cancer|February 23, 2008
All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemiaGerardo Quezada, Lisa Kopp, Elihu Estey, et al.
Thrombosis Research|March 21, 2016
Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopeniaBethany T Samuelson, Terry Gernsheimer, Elihu Estey, et al.
Leukemia & Lymphoma|November 17, 2006
Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?Apostolia-Maria Tsimberidou, Hagop Kantarjian, Michael J Keating, et al.
Blood Reviews|February 14, 2017
Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemiaMary-Elizabeth Percival, Catherine Lai, Elihu Estey, et al.
Leukemia & Lymphoma|August 3, 2012
Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemiaAndrew Lin, Megan Othus, Amy McQuary, et al.
American Journal of Hematology|June 15, 2017
Day 14 bone marrow examination in the management of acute myeloid leukemiaChristopher M Terry, Rory M Shallis, Elihu Estey, et al.
Pageof 16

Showing results (41-50 of 158) with videos related to

Sort By:
Pageof 16
Blood|June 10, 2021
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimalElihu Estey, Robert P Hasserjian, Hartmut Döhner
Leukemia Research|May 4, 2004
FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotypeMiloslav Beran, Rajyalakshmi Luthra, Hagop Kantarjian, et al.
Mayo Clinic Proceedings|February 14, 2006
Adult acute myeloid leukemiaElias J Jabbour, Elihu Estey, Hagop M Kantarjian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Decitabine in older adults with acute myeloid leukemia: why was the dream broken?Hagop Kantarjian, Wyndham Wilson, Farhad Ravandi, et al.
Pediatric Blood & Cancer|February 23, 2008
All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemiaGerardo Quezada, Lisa Kopp, Elihu Estey, et al.
Thrombosis Research|March 21, 2016
Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopeniaBethany T Samuelson, Terry Gernsheimer, Elihu Estey, et al.
Leukemia & Lymphoma|November 17, 2006
Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?Apostolia-Maria Tsimberidou, Hagop Kantarjian, Michael J Keating, et al.
Blood Reviews|February 14, 2017
Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemiaMary-Elizabeth Percival, Catherine Lai, Elihu Estey, et al.
Leukemia & Lymphoma|August 3, 2012
Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemiaAndrew Lin, Megan Othus, Amy McQuary, et al.
American Journal of Hematology|June 15, 2017
Day 14 bone marrow examination in the management of acute myeloid leukemiaChristopher M Terry, Rory M Shallis, Elihu Estey, et al.
Pageof 16